MedPath

Effect Ayurveda decoctions, tablet and Panchagavya on COVID 19

Phase 3
Conditions
Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere
Registration Number
CTRI/2020/08/026980
Lead Sponsor
rashtriyakamdhenu ayog
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Subjects not enrolled in other clinical studies

Patients who fulfils the Diagnostic features of COVID â?? 19 (Only symptomatic patients)

Laboratory test positive for COVID â?? 19

Age of patients more than 10 years -90 years

Both male and female patients.

Exclusion Criteria

•Asymptomatic COVID â?? 19 patients will not be included

•Seriously ill critical patients

•Presenting serious symptoms

•Suffering from complications

• Age below 10 years

•Vulnerable participants

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Primary outcome: Patient becoming asymptomatic <br/ ><br>Secondary outcome: COVID 19 RT PCR becoming negative <br/ ><br>Timepoint: At 7 days and 15 days
Secondary Outcome Measures
NameTimeMethod
COVID 19 RT PCR becoming negative <br/ ><br>Timepoint: 7 days and 15 days
© Copyright 2025. All Rights Reserved by MedPath